You just read:

Blueprint Medicines Announces Proof-of-Concept Data from Global Phase 1 Clinical Trial of BLU-554 in Patients with Advanced Hepatocellular Carcinoma

News provided by

Blueprint Medicines Corporation

28 Nov, 2016, 18:01 ET